HUMA
Humacyte, Inc.$0.56-0.00 (-0.11%)Prev Close$0.56·MCap$95.4M·P/E—·Vol2.82M·Yield—
▲
Buys (12M)
5
$90.2K
▼
Sells (12M)
2
$82.3K
◆
Net Activity
Net Buyer
$7.9K
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Humacyte, Inc. (HUMA) has been mixed between buying and selling, with 5 insider purchases totaling $90.2K and 2 insider sales totaling $82.3K. The most recent insider transaction was by Jones Keith Anthony (director), who purchased $5.6K worth of shares on Sep 15, 2026. Humacyte, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $95.4M.
HUMA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Jones Keith Anthony | director | Buy | 10,000 | $0.56 | $5.6K | 50,000+25% |
| Aug 21, 2026 | Jones Keith Anthony | director | Buy | 10,000 | $0.69 | $6.9K | 40,000+33% |
| Aug 19, 2026 | Jones Keith Anthony | director | Buy | 30,000 | $0.59 | $17.8K | 30,000 |
| May 20, 2026 | Constantino Michael T. | director | Buy | 11,000 | $0.89 | $9.8K | 43,950+33% |
| May 20, 2026 | Sebelius Kathleen | director | Buy | 56,818 | $0.88 | $50.0K | 148,025+62% |
| May 20, 2026 | Sander Dale A. | officer: CFO and Chief Corp. Dev. Off | Sell | 45,887 | $0.90 | $41.1K | 267,213 |
| May 20, 2026 | Parikh Shamik J | officer: Chief Medical Officer | Sell | 45,887 | $0.90 | $41.1K | 272,713 |
| Aug 18, 2025 | Dougan Brady W | Director | Sell | 1,649,360 | $1.70 | $2.80M1.1% OS | 0 |
| Aug 18, 2025 | Niklason Laura E | President, CEO and Director | Sell | 591,685 | $1.58 | $934.9K | 0 |
| Apr 14, 2025 | Scheessele William John | Chief Commercial Officer | Buy | 6,493 | $1.54 | $10.0K | 0 |
| Apr 10, 2025 | Parikh Shamik J | Chief Medical Officer | Buy | 7,500 | $1.55 | $11.6K | 0 |
| Apr 10, 2025 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20,000 | $1.53 | $30.6K | 0 |
| Apr 8, 2025 | Green Charles Bruce | Director | Buy | 6,000 | $1.29 | $7.7K | 0 |
| Apr 8, 2025 | Sebelius Kathleen | Director | Buy | 50,000 | $1.32 | $66.0K | 0 |
| Apr 7, 2025 | Constantino Michael T. | Director | Buy | 16,000 | $1.26 | $20.2K | 0 |
| Dec 4, 2024 | Constantino Michael T. | Director | Buy | 4,600 | $4.39 | $20.2K | 16,950+37% |
| Nov 21, 2024 | Niklason Laura E | President, CEO and Director | Buy | 1,797 | $4.44 | $8.0K | 243,851 |
| Nov 20, 2024 | Niklason Laura E | President, CEO and Director | Sell | 1,500,000 | $4.40 | $6.61M1.0% OS | 2,419,712-38% |
| Sep 11, 2024 | Dougan Brady W | Director | Sell | 446,378 | $5.30 | $2.36M | 3,519,558 |
| Sep 11, 2024 | Sebelius Kathleen | Director | Sell | 5,182 | $5.40 | $28.0K | 41,207 |
| Sep 3, 2024 | Niklason Laura E | President, CEO and Director | Buy | 1,222 | $6.55 | $8.0K | 242,054 |
| Aug 29, 2024 | Dougan Brady W | Director | Sell | 881,878 | $6.49 | $5.72M0.6% OS | 4,306,464 |
| Aug 29, 2024 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Sell | 39,389 | $6.68 | $263.1K | 2,000-95% |
| Aug 15, 2024 | Constantino Michael T. | Director | Buy | 3,100 | $6.29 | $19.5K | 12,350+34% |
| Jun 13, 2024 | Niklason Laura E | President, CEO and Director | Sell | 630,148 | $7.17 | $4.52M | 4,907,288 |
| Jun 4, 2024 | Niklason Laura E | President, CEO and Director | Buy | 2,362 | $6.35 | $15.0K | 240,832 |
| Jun 4, 2024 | Niklason Laura E | President, CEO and Director | Sell | 1,001,852 | $7.82 | $7.83M0.6% OS | 5,474,567 |
| Jun 3, 2024 | Niklason Laura E | President, CEO and Director | Buy | 2,050 | $7.37 | $15.1K | 238,470 |
| Jun 3, 2024 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 191,511 | $8.15 | $1.56M | 2,625-99% |
| May 21, 2024 | Wallace Max N. | Director | Buy | 8,005 | $6.25 | $50.0K | 4,015 |
| May 15, 2024 | Binder Gordon M | Director | Buy | 100,000 | $6.68 | $667.5K | 160,000+167% |
| Sep 15, 2023 | Niklason Laura E | President, CEO and Director | Sell | 2,000,000 | $2.78 | $5.56M1.3% OS | 6,191,140 |
| Aug 21, 2023 | Niklason Laura E | President, CEO and Director | Sell | 1,799,596 | $3.54 | $6.38M1.1% OS | 9,420,562 |
| Jun 16, 2023 | Niklason Laura E | President, CEO and Director | Sell | 500,000 | $3.12 | $1.56M | 9,990,736 |
| Jun 15, 2023 | Niklason Laura E | President, CEO and Director | Sell | 4,875,000 | $2.60 | $12.68M3.1% OS | 10,490,736-32% |
| May 26, 2023 | Niklason Laura E | President, CEO and Director | Sell | 2,625,000 | $2.75 | $7.22M1.7% OS | 15,365,736 |
| May 26, 2023 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 23,402 | $4.01 | $93.9K | 64,566-27% |
| May 19, 2023 | Constantino Michael T. | Director | Buy | 4,750 | $4.18 | $19.9K | 9,250+106% |
| Dec 19, 2022 | Niklason Laura E | President, CEO and Director | Buy | 10,000 | $2.54 | $25.4K | 1,170,240 |
| Dec 19, 2022 | Niklason Laura E | President, CEO and Director | Sell | 239,538 | $2.53 | $606.0K | 17,990,736 |
| Dec 19, 2022 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20,000 | $2.60 | $52.0K | 20,600New Position |
| Dec 15, 2022 | Niklason Laura E | President, CEO and Director | Sell | 699,730 | $2.78 | $1.95M | 18,600,004 |
| Dec 15, 2022 | Scheessele William John | Chief Commercial Officer | Buy | 5,000 | $3.09 | $15.4K | 15,525+48% |
| Sep 19, 2022 | Niklason Laura E | President, CEO and Director | Buy | 2,000 | $4.14 | $8.3K | 1,160,240 |
| Sep 19, 2022 | Niklason Laura E | President, CEO and Director | Sell | 1,522,500 | $4.00 | $6.09M1.0% OS | 18,930,004 |
| Sep 6, 2022 | Binder Gordon M | Director | Buy | 61,841 | $4.40 | $272.1K | 110,000+128% |
| Sep 1, 2022 | Binder Gordon M | Director | Buy | 48,159 | $4.00 | $192.6K | 48,159 |
| May 25, 2022 | Dougan Brady W | Director | Buy | 10,000 | $4.83 | $48.3K | 1,158,240 |
| May 25, 2022 | Scheessele William John | Chief Commercial Officer | Buy | 10,525 | $4.72 | $49.7K | 10,525 |
| May 24, 2022 | Constantino Michael T. | Director | Buy | 2,000 | $4.83 | $9.7K | 4,500+80% |
HUMA Insider Buying Activity
The following table shows recent insider purchases of Humacyte, Inc. (HUMA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Jones Keith Anthony | director | Buy | 10,000 | $0.56 | $5.6K | 50,000+25% |
| Aug 21, 2026 | Jones Keith Anthony | director | Buy | 10,000 | $0.69 | $6.9K | 40,000+33% |
| Aug 19, 2026 | Jones Keith Anthony | director | Buy | 30,000 | $0.59 | $17.8K | 30,000 |
| May 20, 2026 | Constantino Michael T. | director | Buy | 11,000 | $0.89 | $9.8K | 43,950+33% |
| May 20, 2026 | Sebelius Kathleen | director | Buy | 56,818 | $0.88 | $50.0K | 148,025+62% |
| Apr 14, 2025 | Scheessele William John | Chief Commercial Officer | Buy | 6,493 | $1.54 | $10.0K | 0 |
| Apr 10, 2025 | Parikh Shamik J | Chief Medical Officer | Buy | 7,500 | $1.55 | $11.6K | 0 |
| Apr 10, 2025 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20,000 | $1.53 | $30.6K | 0 |
| Apr 8, 2025 | Green Charles Bruce | Director | Buy | 6,000 | $1.29 | $7.7K | 0 |
| Apr 8, 2025 | Sebelius Kathleen | Director | Buy | 50,000 | $1.32 | $66.0K | 0 |
| Apr 7, 2025 | Constantino Michael T. | Director | Buy | 16,000 | $1.26 | $20.2K | 0 |
| Dec 4, 2024 | Constantino Michael T. | Director | Buy | 4,600 | $4.39 | $20.2K | 16,950+37% |
| Nov 21, 2024 | Niklason Laura E | President, CEO and Director | Buy | 1,797 | $4.44 | $8.0K | 243,851 |
| Sep 3, 2024 | Niklason Laura E | President, CEO and Director | Buy | 1,222 | $6.55 | $8.0K | 242,054 |
| Aug 15, 2024 | Constantino Michael T. | Director | Buy | 3,100 | $6.29 | $19.5K | 12,350+34% |
| Jun 4, 2024 | Niklason Laura E | President, CEO and Director | Buy | 2,362 | $6.35 | $15.0K | 240,832 |
| Jun 3, 2024 | Niklason Laura E | President, CEO and Director | Buy | 2,050 | $7.37 | $15.1K | 238,470 |
| May 21, 2024 | Wallace Max N. | Director | Buy | 8,005 | $6.25 | $50.0K | 4,015 |
| May 15, 2024 | Binder Gordon M | Director | Buy | 100,000 | $6.68 | $667.5K | 160,000+167% |
| May 19, 2023 | Constantino Michael T. | Director | Buy | 4,750 | $4.18 | $19.9K | 9,250+106% |
| Dec 19, 2022 | Niklason Laura E | President, CEO and Director | Buy | 10,000 | $2.54 | $25.4K | 1,170,240 |
| Dec 19, 2022 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Buy | 20,000 | $2.60 | $52.0K | 20,600New Position |
| Dec 15, 2022 | Scheessele William John | Chief Commercial Officer | Buy | 5,000 | $3.09 | $15.4K | 15,525+48% |
| Sep 19, 2022 | Niklason Laura E | President, CEO and Director | Buy | 2,000 | $4.14 | $8.3K | 1,160,240 |
| Sep 6, 2022 | Binder Gordon M | Director | Buy | 61,841 | $4.40 | $272.1K | 110,000+128% |
| Sep 1, 2022 | Binder Gordon M | Director | Buy | 48,159 | $4.00 | $192.6K | 48,159 |
| May 25, 2022 | Dougan Brady W | Director | Buy | 10,000 | $4.83 | $48.3K | 1,158,240 |
| May 25, 2022 | Scheessele William John | Chief Commercial Officer | Buy | 10,525 | $4.72 | $49.7K | 10,525 |
| May 24, 2022 | Constantino Michael T. | Director | Buy | 2,000 | $4.83 | $9.7K | 4,500+80% |
HUMA Insider Selling Activity
The following table shows recent insider sales of Humacyte, Inc. (HUMA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Sander Dale A. | officer: CFO and Chief Corp. Dev. Off | Sell | 45,887 | $0.90 | $41.1K | 267,213 |
| May 20, 2026 | Parikh Shamik J | officer: Chief Medical Officer | Sell | 45,887 | $0.90 | $41.1K | 272,713 |
| Aug 18, 2025 | Dougan Brady W | Director | Sell | 1,649,360 | $1.70 | $2.80M1.1% OS | 0 |
| Aug 18, 2025 | Niklason Laura E | President, CEO and Director | Sell | 591,685 | $1.58 | $934.9K | 0 |
| Nov 20, 2024 | Niklason Laura E | President, CEO and Director | Sell | 1,500,000 | $4.40 | $6.61M1.0% OS | 2,419,712-38% |
| Sep 11, 2024 | Dougan Brady W | Director | Sell | 446,378 | $5.30 | $2.36M | 3,519,558 |
| Sep 11, 2024 | Sebelius Kathleen | Director | Sell | 5,182 | $5.40 | $28.0K | 41,207 |
| Aug 29, 2024 | Dougan Brady W | Director | Sell | 881,878 | $6.49 | $5.72M0.6% OS | 4,306,464 |
| Aug 29, 2024 | Sander Dale A. | CFO and Chief Corp. Deve. Off. | Sell | 39,389 | $6.68 | $263.1K | 2,000-95% |
| Jun 13, 2024 | Niklason Laura E | President, CEO and Director | Sell | 630,148 | $7.17 | $4.52M | 4,907,288 |
| Jun 4, 2024 | Niklason Laura E | President, CEO and Director | Sell | 1,001,852 | $7.82 | $7.83M0.6% OS | 5,474,567 |
| Jun 3, 2024 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 191,511 | $8.15 | $1.56M | 2,625-99% |
| Sep 15, 2023 | Niklason Laura E | President, CEO and Director | Sell | 2,000,000 | $2.78 | $5.56M1.3% OS | 6,191,140 |
| Aug 21, 2023 | Niklason Laura E | President, CEO and Director | Sell | 1,799,596 | $3.54 | $6.38M1.1% OS | 9,420,562 |
| Jun 16, 2023 | Niklason Laura E | President, CEO and Director | Sell | 500,000 | $3.12 | $1.56M | 9,990,736 |
| Jun 15, 2023 | Niklason Laura E | President, CEO and Director | Sell | 4,875,000 | $2.60 | $12.68M3.1% OS | 10,490,736-32% |
| May 26, 2023 | Niklason Laura E | President, CEO and Director | Sell | 2,625,000 | $2.75 | $7.22M1.7% OS | 15,365,736 |
| May 26, 2023 | Prichard Heather Ledbetter | Chief Operating Officer | Sell | 23,402 | $4.01 | $93.9K | 64,566-27% |
| Dec 19, 2022 | Niklason Laura E | President, CEO and Director | Sell | 239,538 | $2.53 | $606.0K | 17,990,736 |
| Dec 15, 2022 | Niklason Laura E | President, CEO and Director | Sell | 699,730 | $2.78 | $1.95M | 18,600,004 |
| Sep 19, 2022 | Niklason Laura E | President, CEO and Director | Sell | 1,522,500 | $4.00 | $6.09M1.0% OS | 18,930,004 |
HUMA Insiders
Sander Dale A.
officer: CFO and Chief Corp. Dev. Off
Bought $82.6KSold $304.3K
4 tradesLast: May 20, 2026
Similar Stocks to HUMA
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B